Ceapro Inc (CZO) - Financial and Strategic SWOT Analysis Review

  • ID: 4302709
  • SWOT Analysis
  • 52 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Alphora Research Inc
  • Apotex Pharmachem Inc
  • Aptose Biosciences Inc
  • Microbix Biosystems Inc
  • Nymox Pharmaceutical Corp
  • Sernova Corp
  • MORE
Ceapro Inc (CZO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Ceapro Inc (Ceapro) is a biotechnology company which develops proprietary extraction technologies for use in the production of extracts and active ingredients from oats and other renewable plant resources. The company’s extracts are also used in nutraceutical, cosmeceutical, and therapeutics products for humans and animals. Ceapro’s portfolio includes natural active ingredients comprising oat avenanthramides, oat oil, oat peptides, oat beta glucan, and lupin peptides; and veterinary products including oat shampoo, ear cleanser and dermal complex/conditioner. The company offers its products in Canada, United States, Germany, China and other countries. Ceapro is headquartered in Edmonton, Alberta, Canada.

Ceapro Inc Key Recent Developments

Jun 13, 2018: Ceapro Announces Data from Avenanthramides Study Presented at the Nutrition 2018 Meeting
May 29, 2018: Ceapro Confirms Excellent Bioavailability of its New Water Soluble Chemical Complex Coenzyme Q10-Beta Glucan
May 17, 2018: Ceapro Announces 2018 First Quarter Results
Apr 23, 2018: Ceapro Provides Corporate Update - Company well poised to transition to its next phase of growth for expansion into the profitable nutraceutical sector
Apr 20, 2018: Ceapro Reports 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Alphora Research Inc
  • Apotex Pharmachem Inc
  • Aptose Biosciences Inc
  • Microbix Biosystems Inc
  • Nymox Pharmaceutical Corp
  • Sernova Corp
  • MORE
Section 1 - About the Company
  • Ceapro Inc - Key Facts
  • Ceapro Inc - Key Employees
  • Ceapro Inc - Key Employee Biographies
  • Ceapro Inc - Major Products and Services
  • Ceapro Inc - History
  • Ceapro Inc - Company Statement
  • Ceapro Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Ceapro Inc - Business Description
  • Ceapro Inc - Corporate Strategy
  • Ceapro Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Ceapro Inc - Strengths
  • Ceapro Inc - Weaknesses
  • Ceapro Inc - Opportunities
  • Ceapro Inc - Threats
  • Ceapro Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Ceapro Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 13, 2018: Ceapro Announces Data from Avenanthramides Study Presented at the Nutrition 2018 Meeting
  • May 29, 2018: Ceapro Confirms Excellent Bioavailability of its New Water Soluble Chemical Complex Coenzyme Q10-Beta Glucan
  • Apr 23, 2018: Ceapro Provides Corporate Update - Company well poised to transition to its next phase of growth for expansion into the profitable nutraceutical sector
  • Apr 20, 2018: Ceapro Reports 2017 Financial Results
  • Apr 18, 2018: Ceapro Announces Important Collaboration with Prestigious Montreal Heart Institute
  • Apr 13, 2018: Ceapro to Present at the 12th International Symposium on Supercritical Fluids
  • Apr 03, 2018: Ceapro Announces Acceptance of Abstract for Presentation at the Nutrition 2018 Meeting
  • Nov 15, 2017: Ceapro Reports 2017 Third Quarter Business Update and Financial Results
  • Aug 18, 2017: Ceapro Reports 2017 Second Quarter Business Update and Financial Results
  • Jun 01, 2017: Ceapro Announces its First Major Milestones with its PGX Enabling Technology
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Ceapro Inc, Key Facts
  • Ceapro Inc, Key Employees
  • Ceapro Inc, Key Employee Biographies
  • Ceapro Inc, Major Products and Services
  • Ceapro Inc, History
  • Ceapro Inc, Subsidiaries
  • Ceapro Inc, Key Competitors
  • Ceapro Inc, Ratios based on current share price
  • Ceapro Inc, Annual Ratios
  • Ceapro Inc, Annual Ratios (Cont...1)
  • Ceapro Inc, Annual Ratios (Cont...2)
  • Ceapro Inc, Interim Ratios
  • Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Ceapro Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Ceapro Inc, Performance Chart (2013 - 2017)
  • Ceapro Inc, Ratio Charts
  • Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Ceapro Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Sernova Corp
  • Nymox Pharmaceutical Corp
  • Microbix Biosystems Inc
  • Generex Biotechnology Corp
  • Aptose Biosciences Inc
  • Apotex Pharmachem Inc
  • Alphora Research Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll